Defunct Company
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
83
NCT01041755
Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
Phase: Phase 4
Role: Collaborator
Start: Nov 30, 2009
Completion: Jun 30, 2011
NCT04516915
IMU-838 and Oseltamivir in the Treatment of COVID-19
Phase: Phase 2
Start: Jun 15, 2020
Completion: Sep 21, 2022
NCT05536570
Whiplash-induced Thoracic Outlet Syndrome Treated With Botulinum Toxin.
Start: Oct 15, 2022
Completion: Jun 15, 2023